BioPharma APAC

Berry Oncology Launches an Innovative Self-Iterative "HIFI" System

The HIFI system consists of HIFI-det liquid biopsy technology and the corresponding HIFI-cal series of algorithms. With the commercial application of NGS ...

May 19, 2022 | News

SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer

SCG101 is the first TCR-T cell therapy product to receive a multi-regional Investigational New Drug (IND) approval from Singapore's Health Scie...

May 09, 2022 | News

Porton Advanced and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Cell Therapy Development for Solid Tumors

Porton Advanced offers an end-to-end gene and cell therapy CDMO service platform covering plasmids, cell therapy, gene therapy, oncolytic virus, mRNA thera...

April 26, 2022 | News

GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn

Sierra Oncology’s differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia ...

April 14, 2022 | News

Omega Healthcare completes acquisition of ApexonHealth and Vasta Global

ApexonHealth leverages its digital solutions to deliver comprehensive technology-enabled services for both providers and payors from revenue cycle manageme...

April 14, 2022 | News

Jackson ImmunoResearch announces new range of detection reagents for R&D and diagnostic markets

Jackson ImmunoResearch, manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new range of detection reagents th...

April 13, 2022 | News

Debiopharm announces oncology research advancements

Debiopharm, (www.debiopharm.com/debiopharm-international/) an oncology and infectious disease focused biopharmaceutical company based in Switzerland, ...

April 12, 2022 | News

Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab

Telix Pharmaceuticals Limited (ASX: TLX, "Telix", the "Company") today announces that it has entered into a licence agreement with Eli Lilly and Comp...

April 11, 2022 | News

BioVaxys Expands Cancer Vaccine Platform

BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today the expansion of its cancer vaccine platf...

March 31, 2022 | News

Free Guide to Colorectal Cancer Screening from NCCN Now Available in More Than a Dozen Languages

The National Comprehensive Cancer Network® (NCCN®) today announced new translations of the recently-published NCCN Guidelines for Pa...

March 28, 2022 | News

Innovent and Lilly Expand Strategic Partnership in Oncology

i) an agreement for Innovent to obtain the sole commercialization rights to import, market, promote, distribute and detail Cyramza® (ramucirumab) ...

March 28, 2022 | News

Telix Advances Development of Glioblastoma Therapy Program

TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of the Company's lead therapeutic clinical programs and has been granted orphan drug design...

March 23, 2022 | News

Gene Solutions Makes Earlier Detection of Cancer A Possibility of the Future

Globally, cancer causes one in six deaths with more than 21 million people developing annually. 70% of cancers in patients are detected at late stages in w...

March 16, 2022 | News

China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors

-BeiGene, Ltd. , a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and...

March 14, 2022 | News

Stay Connected